intezyne.com intezyne.com

intezyne.com

Intezyne

Developing Breakthrough Cancer Therapies Learn More

http://www.intezyne.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INTEZYNE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 9 reviews
5 star
2
4 star
6
3 star
1
2 star
0
1 star
0

Hey there! Start your review of intezyne.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.1 seconds

FAVICON PREVIEW

  • intezyne.com

    16x16

  • intezyne.com

    32x32

  • intezyne.com

    64x64

CONTACTS AT INTEZYNE.COM

Intezyne

Kevin Sill

3720 Spec●●●●●●●●●Suite 104

Ta●●pa , FL, 33612

US

1.81●●●●2120
ke●●●●●●●●@intezyne.com

View this contact

Intezyne

Kevin Sill

3720 Spec●●●●●●●●●Suite 104

Ta●●pa , FL, 33612

US

1.81●●●●2120
ke●●●●●●●●@intezyne.com

View this contact

Registercom

Domain Registrar

12808 ●●●●●●y Pkwy

West J●●●●●●nville , FL, 32258

US

1.90●●●●2701
1.90●●●●2701
do●●●●●●●●●●●●●@register.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2004 February 15
UPDATED
2014 June 17
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 20

    YEARS

  • 3

    MONTHS

  • 3

    DAYS

NAME SERVERS

1
ns1.bayshorehosting.com
2
ns2.bayshorehosting.com
3
ns3.bayshorehosting.com

REGISTRAR

REGISTER.COM, INC.

REGISTER.COM, INC.

WHOIS : whois.register.com

REFERRED : http://www.register.com

CONTENT

SCORE

6.2

PAGE TITLE
Intezyne | intezyne.com Reviews
<META>
DESCRIPTION
Developing Breakthrough Cancer Therapies Learn More
<META>
KEYWORDS
1 management team
2 board of directors
3 clinical advisory board
4 partnerships
5 careers
6 technology
7 pipeline
8 publications
9 investors
10 overview
CONTENT
Page content here
KEYWORDS ON
PAGE
management team,board of directors,clinical advisory board,partnerships,careers,technology,pipeline,publications,investors,overview,back to top
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Intezyne | intezyne.com Reviews

https://intezyne.com

Developing Breakthrough Cancer Therapies Learn More

INTERNAL PAGES

intezyne.com intezyne.com
1

Intezyne News

http://intezyne.com/content/media/default.php

Jan 9, 2015. Intezyne Technologies Announces Formation of its Clinical Advisor Board. Jul 10, 2014. Intezyne Technologies Expands Executive Leadership Team with Two Key Appointments. May 15, 2012. Intezyne Adds Chief Business Officer Daniel Devers to Management Team. Jan 25, 2012. Intezyne Scientists Gain Cover Art for the Journal of Polymer Chemistry. Jan 25, 2011. Intezyne Named Company 'On The Rise' by Drug Development and Delivery Magazine. Niiki Pharma News Archive. Jun 19, 2013. May 24, 2012. Niiki...

2

Intezyne Press Releases

http://intezyne.com/content/media/releases/071014.php

Intezyne Technologies Expands Executive Leadership Team with Two Key Appointments. Carolyn Paradise, MD, Joins Intezyne as Acting Chief Medical Officer -. Tim Coan Joins Intezyne as Chief Financial Officer -. Mr Coan retired from Deerfield Partners in 2012 after a five-year career identifying new investment opportunities and contributing to a $2 billion portfolio of healthcare investments. He was instrumental in Deerfield’s investments in ISTA Pharmaceuticals, Salix.

3

Pipeline - IT-235

http://intezyne.com/content/pipeline/it-235.php

Intezyne’s IT-235 is a first-in-class targeted gallium-based small molecule administered as oral tablets once daily. The Company is planning to conduct a Phase 1 trial for IT-235 in patients with metastatic solid tumors that are resistant to standard therapies. An Investigational New Drug (IND) application for IT-235 has been cleared by the U.S. Food and Drug Administration, and Intezyne intends to initiate the Phase 1 trial in the United States shortly.

4

Intezyne Press Releases

http://intezyne.com/content/media/releases/010915.php

Intezyne Technologies Announces Formation of its Clinical Advisor Board. Ldquo;We are exceptionally pleased to welcome Drs. Kelsen, Solit, Kulke, and Lee to Intezyne’s extended family. Advice from these experienced clinical and basic science investigators will help to guide the development of agents such as IT-139, our lead product candidate that targets GRP78, a cell-regulating protein, and the IVECT platform,” stated Habib Skaff, PhD, Chairman, President, and CEO of Intezyne.

5

Intezyne Pipeline

http://intezyne.com/content/pipeline/default.php

Intezyne’s product pipeline is comprised of two distinct categories of oncology assets:. First-in-class drugs targeting pathways in the endoplasmic reticulum of the cancer cell (IT-139 and IT-235); and. A series of novel drugs based on the Company’s breakthrough IVECT™ nanoparticle platform (includes IT-141, IT-143, and IT-147). Encapsulates daunorubicin in the IVECT micelle nanoparticle. Utilizing the IVECT Method technology, IT-143 has demonstrated a 75-fold increase in tumor accumulation when comp...

UPGRADE TO PREMIUM TO VIEW 3 MORE

TOTAL PAGES IN THIS WEBSITE

8

LINKS TO THIS WEBSITE

gastoncapitalpartners.com gastoncapitalpartners.com

The William Gaston Fund - Gaston Capital Partners

http://www.gastoncapitalpartners.com/the-william-gaston-fund.html

The William Gaston Fund. The William Gaston Income Fund. The William Gaston Fund. The William Gaston Income Fund. The William Gaston Fund. GROWTH AND EFFECTIVE MANAGEMENT ARE OUR WATCHWORDS. Have demonstrated growth potential and innovation across industrial classifications. Intezyne is a clinical-stage company with an extensive portfolio of product candidates that may offer physicians and patients significant advances in treating a wide variety of tumors. The Company’s portfolio is comprised o...Produce...

lifesciencessummit.org lifesciencessummit.org

2014 Company Presenters | Life Sciences Summit

http://lifesciencessummit.org/2014-presentations

November 2-3, 2016. 10 on the Park ●. Innovative, Fundable, Early Stage Opportunities. Presentations from early-stage companies with innovative technologies and proven management. Click on the logo below to view the company’s presentation from the 2014 Life Sciences Summit . President and CEO Jerry McLaughlin. Previously NuPathe, Merck and Endo Pharmaceuticals. CEO Joe Blanchard, MBA. Rockville, MD: BioMarker Strategies is a privately held Maryland-based company that has pioneered development of the Snap...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

2

OTHER SITES

intezmenyuzemeltetes.hu intezmenyuzemeltetes.hu

Ferencvárosi Intézmény Üzemeltetési Központ

Budapest Főváros IX. Kerület Ferencváros Önkormányzata. 1097 Budapest, Vágóhíd utca 35-37. Budapest IX. Kerületi Kosztolányi Dezső Általános Iskola. Bakáts Téri Ének-Zenei Általános Iskola. Budapest IX. Kerületi Szent-Györgyi Albert Általános Iskola és Gimnázium. Ferencvárosi Ádám Jenő Zeneiskola Alapfokú Művészetoktatási Intézmény. Budapest IX. Kerületi Telepy Károly Testnevelési Általános Iskola és Gimnázium. Budapest IX. Kerületi József Attila Általános Iskola és Alapfokú Művészeti Iskola.

intezmenyvezetes.hu intezmenyvezetes.hu

Magazin - Intézményvezetés.hu - Szakmai portál közoktatási intézmények vezetőinek

Szakmai portál közoktatási intézmények vezetőinek. Igényeljen új jelszót itt! Elfogadták a Magyar Képesítési Keretrendszerről szóló jelentést. Az Európai Képesítési Keretrendszert (EKKR) felügyelő tanácsadó testület elfogadta a Magyar Képesítési Keretrendszerről szóló jelentést jelentette be a felsőoktatásért felelős helyettes államtitkár kedden Budapesten. tovább. Novák Katalin: több mint egymilliárd forint jut idén az ifjúsági területre az Erasmus programban. A kormány a kistelepüléseken élők számára i...

intezo.com intezo.com

H I B A

Az Ön által keresett oldal még nincs beállítva a szerveren. Kérjük látogasson vissza késõbb!

intezo.info intezo.info

INTEZO - zateplování staveb, fasádní obklady, tepelná izolace,sekční garážová vrata

INTEZO - zateplování staveb, fasádní obklady, tepelná izolace,sekční garážová vrata. Jak se to dělá. WOLF - akustické systémy. Jak jste nás našli? Zvukově izolační desky WOLF. 420 603 428 330. 420 777 316 919. Obklady a zednické práce. Jak se to dělá. WOLF - akustické systémy. Design and System by ART OF PRODUCTION. 2008-2011 Redakční systém AIA.

intezon.net intezon.net

New Venture – Intezon

Beyond the Search Bar…. You must be logged in to see more details. Please login or register from the main menu!

intezyne.com intezyne.com

Intezyne

IT-139: A Novel Cancer Resistance Pathway Inhibitor. IT-141: A Novel TOP-1 Inhibitor. IT-147: A Novel Antimicrotubule Agent. News / Press Releases. IT-139: A Novel Cancer Resistance Pathway Inhibitor. IT-141: A Novel TOP-1 Inhibitor. IT-147: A Novel Antimicrotubule Agent. News / Press Releases. Developing Breakthrough Cancer Therapies. Intezyne, Inc., 3720 Spectrum Blvd., Suite 104, Tampa, FL 33612, USA.

intezzy.eu intezzy.eu

inteZZy.eu ~ minecraft server

IP: play.intezzy.eu. Vítejte na oficiální stránce portálu intezzy.eu server vám nabízí kvalitní minihry (Bedwars and Annihilation) které jsou zatím v Beta fázi , samozřejmě připravujeme spousty dalších miniher. Je zde i k dispozici VIP , s kterým získáte spousty výhod. Dnes, akorát koncem prosince jsme oficiálně spustili nový projekt InteZZy.eu. Dňa: 25.12.2014. Po prispení akejkoľvek čiastky Vás čaká malé prekvapenie ;-). Intezzy.eu MC server. 17 - 1.8. IP: ts3.intezzy.eu. 2014 - 2015 Intezzy.eu.

intf.adanabtu.edu.tr intf.adanabtu.edu.tr

Adana Bilim ve Teknoloji Üniversitesi

Rehberimiz Bilim, IÅ Ä Ä Ä mÄ z Teknoloji. UluslararasÄ Ticaret ve Finansman. à alÄ Å ma AlanlarÄ. Neden AdanaBTà UluslararasÄ Ticaret ve Finans. UluslararasÄ Ticaret ve Finansman Bà là mÃ. Leeds Beckett à niv. ile Ortak Bà là m. Bà là m VideolarÄ. Ortak Program TanÄ tÄ m. Normal Program TanÄ tÄ m. Normal Program Lisans Ders KataloÄ u. Ortak Program Lisans Ders KataloÄ u. UluslararasÄ Ticaret ve Finasman. Leeds Beckett à niversitesi Ä le Ortak Program. Kampà sà mà z hakkÄ nda. Ekonomi BakanlÄ Ä Ä.

intf.ajmuste.org intf.ajmuste.org

International Nonviolence Training Fund

AJ MUSTE MEMORIAL INSTITUTE. Supporting Nonviolence and Social Justice Since 1974. 339 Lafayette Street, New York, New York 10012 (212) 533-4335 Fax: (212) 228-6193 info@ajmuste.org. Who was A.J. Muste? International Nonviolence Training Fund (INTF). Of the A.J. Muste Memorial Institute. Created in 1994, the Muste Institute's International Nonviolence Training Fund (INTF) supports communities engaged in nonviolent struggles by making grants of up to $4,000 for:. Read our INTF grant guidelines here. Suppo...

intf.baike.360.cn intf.baike.360.cn

软件百科_360安全中心 - 360安全卫士官方网站

It is ok 详细.

intf.bl.ee intf.bl.ee

自動リンク 奢侈文弱

解 説 奢侈 は度を越えたぜいたく。 用 例 奢侈文弱の弊へいを戒いましめ勤倹力行の風俗を奨励し都会に汚されずしてドシドシ健全の血液を都会に送るは 徳富蘆花 思出の記. 以上、発リンク数 100 以内のサイトは 新規登録フォーム. Http:/ www.vspromet.com/. 高血圧の原因 症状 予防方法は 高血圧改善の食事レシピも. アルツハイマー型認知症の 予防 治療方法 と 症状 原因. Http:/ www.vspromet.com/. Http:/ www.leap2.net/. Http:/ www.nateonbiz.com/. この続きは サイト集 グループ 1.